SGLT2抑制剂的免疫调节作用 - - 针对衰老中的炎症和氧化应激
Ema Schönberger1,2, Vjera Mihaljević3, Kristina Steiner1
1Department of Endocrinology, University Hospital Osijek, 31000 Osijek, Croatia.
International journal of environmental research and public health
|September 8, 2023
概括
-葡萄糖共载体2 (SGLT2) 抑制剂通过减少炎症和氧化应激,显示出潜在的抗衰老作用. 需要进一步的研究来探索它们在与年龄有关的疾病中的复杂机制.
科学领域:
- 老年病学和药理学
- 生物医学科学 生物医学科学
背景情况:
- 人口老龄化带来了重大的公共卫生挑战,炎症和氧化应激是导致与年龄有关的疾病的关键因素.
- 最初用于糖尿病的-葡萄糖共运输体2 (SGLT2) 抑制剂对功能和心血管健康产生有益影响.
- 这些药物具有免疫调节和抗氧化特性,影响内皮功能和代谢参数.
研究的目的:
- 提供SGLT2抑制剂可以对抗衰老和与年龄有关的疾病的病理生理机制的全面概述.
- 探索SGLT2抑制剂的抗炎和抗氧化作用.
- 讨论SGLT2抑制剂作为抗衰老疗法的潜力.
主要方法:
- 这篇叙事综述综合了关于SGLT2抑制剂及其在衰老中的作用的现有文献.
- 它检查了拟议的分子通路,包括AMPK/SIRT1/PGC-1α信号传递,细胞因子调节和NLRP3炎症酶.
- 它还考虑了对线粒体功能,TGF-β和Nrf2/ARE通路以及代谢参数的影响.
主要成果:
- SGLT2 抑制剂通过AMPK/SIRT1/PGC-1α等途径以及细胞因子和NLRP3炎症酶的调节表现出抗炎作用.
- 它们的抗氧化作用源于线粒体的作用和对TGF-β和Nrf2/ARE信号传递的影响.
- 代谢改善,包括尿酸减少,生成刺激,减肥和脂解,有助于它们的抗炎和抗氧化作用.
结论:
- SGLT2 抑制剂表现出与衰老和与年龄相关的疾病相关的多方面的抗炎和抗氧化机制.
- 它们具有抗动脉样硬化性质,可以改善内皮功能.
- 进一步的基础和临床研究对于充分理解和利用SGLT2抑制剂用于抗衰老疗法至关重要.
相关概念视频
Aging
86
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
86
The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Dipeptidyl Peptidase 4 Inhibitors
211
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
211
Psychoneuroimmunology: Diabetes and Cancer
47
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
47
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
203
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
203


